Verdane bought the four-company strong portfolio through its Capital VII fund, which closed above its SEK1.5bn ($237m) target in 2010.
NVP I consists of a €150m venture fund and €70m seed fund raised in 2000, backed by Danish investors including ATP, PensionDanmark, Danske Bank and Sampension.
The combined funds have invested in life sciences service provider CRF Health, newspaper content production and distribution business Saxotech, video streaming service Octoshape and mobile device management company Excitor.
Verdane managing partner Lars Thoresen said, “We are very excited about Verdane funds’ first investment in Denmark.
“We have been looking for suitable acquisitions in Denmark for a while and are very pleased with the opportunity and the interesting companies acquired today.
“Verdane’s goal is to always deliver more than capital. The funds have a track record of doing this in 18 transactions to date, with the investment in Nordic Venture Partners being the 19th in the Nordic Region.
“As part of the acquisition, we have worked in close cooperation with the management of Nordic Venture Partner I funds to ensure the continued development and success of the Danish portfolio.”
Verdane VII is 50 per cent larger than its predecessor, and received investments from seven new LPs and 23 investors in previous funds.
They included AP3, Argentum, Finnish Industry Investment, KLP, Amanda Capital-advised Mandatum Life and RealDania.
Verdane said a quarter of the capital came from outside the region, with commitments from European and US family offices and fund of funds.
In December 2012 Verdane made a six-times return on investment by selling Nordic contact lens company LensOn to Prescription Eyewear, and a four times return selling shipping industry equipment maker TeamTec Invest.
NVP has a second vehicle, a €115m fund raised in 2004.
Copyright © 2013 AltAssets